Shares of Panacea Biotec rose 4.99% on Thursday to the day's high of Rs 456 after the company received a Letter of Award from UNICEF for the supply of a polio vaccine worth approximately US$ 14.95 ...

In collaboration with ICMR, Panacea Biotec will conduct the Phase 3 clinical trial across 19 sites in 18 States and Union ...

Panacea Biotec has secured a $20 million long-term loan from the US International Development Finance Corporation to expand its hexavalent vaccine production. This funding will help the company ...

Panacea Biotec share price locked at 5 percent upper circuit on December 26 following the company received Letter Of Award (LoA) from United Nations International Children's Emergency Fund (UNICEF ...

New Delhi, Jun 10 () Shares of Panacea Biotec on Wednesday zoomed 20 per cent after the company said it is setting up a JV in Ireland with US-based Refana Inc to develop a vaccine for COVID-19.

Panacea Biotec has reached one of its milestones by recently winning the contract from UNICEF to procure 115 million doses of bivalent oral polio vaccine (bOPV) in 2025, valued at ₹127 crore ...

Please find attached herewith the compliance certificate under Regulation 74 (5) of SEBI (Depositories and Participant) Regulations, 2018, for quarter ended December 31, 2024 ...

Panacea Biotec stock opened with a gain of 5 percent to hit an intraday high of Rs 454.90 per share on the NSE. Later, it pared some of the gains to quote at Rs 445.05 apiece, up 2.72 percent at ...

India's Dr. Reddy's open to making Pfizer COVID pill after Merck deal India's Panacea Biotec Ltd (PNCA.NS) said on Thursday it had agreed to produce up to 25 million doses of the Sputnik V COVID ...

Indias leading research-based health management company with established research, manufacturing and marketing capabilities are collectively known as Panacea Biotec Limited (PBL), which was ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...